• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Hercules Capital Reports Third Quarter 2021 Financial Results

    10/28/21 4:10:00 PM ET
    $CPSR
    $DMYQ
    $HCXY
    $HTGC
    Business Services
    Finance
    Investment Managers
    Finance
    Get the next $CPSR alert in real time by email

    Record Q3 Total Gross Debt and Equity Commitments of $719.6 Million

    Record Q3 Total Gross Fundings of $431.1 Million

    Record Year-to-Date Total Gross Debt and Equity Commitments of $1.69 Billion

    Record Year-to-Date Total Gross Fundings of $1.07 Billion

    Record Undistributed Earnings Spillover of $181.7 Million, or $1.57(1) per Ending Shares Outstanding

    Increased the Company's Quarterly Base Cash Distribution to $0.33 per Share

    Closed Public Offering of $325.0 Million 2.625% Notes due 2026

    Q3 2021 Financial Achievements and Highlights

    • Net Investment Income "NII" of $38.1 million, or $0.33 per share
    • Total Investment Income of $70.2 million
    • Record total gross new debt and equity commitments of $719.6 million
      • Record net Hercules' debt and equity commitments of $619.9 million(2)
    • Record total gross fundings of $431.1 million
      • Record net Hercules' fundings of $371.5 million(2)
    • Unscheduled early principal repayments or "early loan repayments" of $318.9 million
    • $818.4 million of available liquidity, subject to existing terms and covenants
    • 12.0% Return on Average Equity "ROAE" (NII/Average Equity)
    • 5.7% Return on Average Assets "ROAA" (NII/Average Assets)
    • GAAP leverage of 106.4% and regulatory leverage of 101.6%(3)
    • Net Asset Value "NAV" of $11.54, a slight decrease of 1.5% from Q2 2021
    • 12.7% GAAP Effective Yield and 11.4% Core Yield(4), a non-GAAP measure

    Year-to-date ending September 30, 2021 Financial Highlights

    • NII of $109.6 million, or $0.95 per share
      • Total investment income of $208.5 million
    • Record total gross new equity and debt commitments of $1.69 billion, an increase of 62.5% year-over-year
      • Record total gross fundings of $1.07 billion, an increase of 69.5% year-over-year
    • Net debt investment portfolio growth of $163.2 million
    • Unscheduled early loan repayments of $678.3 million

    Footnotes:

    1. $1.58 per Weighted Average Shares Outstanding
    2. Net Hercules' commitments and fundings are net of what was assigned to or directly committed or funded by the external funds "Adviser Funds" managed by Hercules Adviser LLC "Hercules Adviser" during the quarter
    3. Regulatory leverage represents debt-to-equity ratio, excluding the Company's Small Business Administration "SBA" debentures
    4. Core Yield excludes early loan repayments and one-time fees, and includes income and fees from expired commitments

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter ended September 30, 2021.

    "Hercules' leadership position, scale and brand reputation as the largest nonbank provider of venture and growth stage debt solutions, combined with a healthy capital markets environment, has created unprecedented deal opportunities in our core verticals with both new and existing portfolio companies," stated Scott Bluestein, chief executive officer and chief investment officer of Hercules. "Our robust origination performance continued through Q3 2021 enabling Hercules to set new annual commitments and funding records of $1.69 billion and $1.07 billion year-to-date, respectively, with a quarter to go in the year."

    Bluestein added, "With our debt investment portfolio at $2.3 billion, at cost, combined with the size of our pipeline and record earnings spillover of nearly $182 million, or $1.57 per share, the Board has made the decision to increase our quarterly base distribution to $0.33 per share and has also declared a supplemental distribution of $0.07 per share for the third quarter. Furthermore, our most recent offering of 2.625% Notes exemplifies our active balance sheet management as we continue to lower our average cost of debt capital over the coming year. Our strong origination activity throughout 2021 has given us the opportunity to fund growth in both our public portfolio as well as our private funds. Given these factors and the overall continued strength of the VC ecosystem, we believe Hercules is exceptionally well positioned heading into Q4 and allowing us to remain focused on delivering strong total shareholder returns."

    Q3 2021 Review and Operating Results

    Debt Investment Portfolio

    Hercules delivered total gross new debt and equity commitments totaling $719.6 million and gross new fundings totaling $431.1 million.

    During the third quarter, Hercules realized early loan repayments of $318.9 million, which along with normal scheduled amortization of $24.2 million, resulted in total debt repayments of $343.1 million.

    The new debt investment origination and funding activities lead to a net debt investment portfolio increase of $23.9 million during the third quarter, on a cost basis.

    The Company's total investment portfolio, (at cost and fair value) by category, quarter-over-quarter is highlighted below:

    Total Investment Portfolio: Q3 2021 to Q2 2021

    Equity & Other
    (in millions) Debt Investments Warrants Total Portfolio
    Balances at Cost at 6/30/21

    $

    2,238.8

     

    $

    135.1

     

    $

    25.1

     

    $

    2,399.0

     

    New fundings(a)

     

    424.9

     

     

    4.3

     

     

    1.9

     

     

    431.1

     

    Fundings assigned to or directly funded by Adviser Funds

     

    (59.1

    )

     

    —

     

     

    (0.5

    )

     

    (59.6

    )

    Principal payments received on investments

     

    (24.2

    )

     

    —

     

     

    —

     

     

    (24.2

    )

    Early payoffs(b)

     

    (318.9

    )

     

    —

     

     

    —

     

     

    (318.9

    )

    Net changes attributed to conversions, liquidations, and fees

     

    1.2

     

     

    (2.6

    )

     

    (0.6

    )

     

    (2.0

    )

    Net activity during Q3 2021

     

    23.9

     

     

    1.7

     

     

    0.8

     

     

    26.4

     

    Balances at Cost at 9/30/21

    $

    2,262.7

     

    $

    136.8

     

    $

    25.9

     

    $

    2,425.4

     

     
     
    Balances at Value at 6/30/21

    $

    2,243.4

     

    $

    231.0

     

    $

    46.7

     

    $

    2,521.1

     

    Net activity during Q3 2021

     

    23.9

     

     

    1.7

     

     

    0.8

     

     

    26.4

     

    Net change in unrealized appreciation (depreciation)

     

    (3.7

    )

     

    (27.3

    )

     

    (4.6

    )

     

    (35.6

    )

    Total net activity during Q3 2021

     

    20.2

     

     

    (25.6

    )

     

    (3.8

    )

     

    (9.2

    )

    Balances at Value at 9/30/21

    $

    2,263.6

     

    $

    205.4

     

    $

    42.9

     

    $

    2,511.9

     

     
    (a) New fundings amount includes $283K associated with revolver loans during Q3 2021.
    (b) Early payoffs include $2.7M paydown on revolvers during Q3 2021.

    Debt Investment Portfolio Balances by Quarter

    (in millions)

    Q3 2021

     

    Q2 2021

     

    Q1 2021

     

    Q4 2020

     

    Q3 2020

     

     

     

     

     

     

     

     

     

    Ending Balance at Cost

    $2,262.7

     

    $2,238.8

     

    $2,182.0

     

    $2,099.5

     

    $2,283.7

     

     

     

     

     

     

     

     

     

    Weighted Average Balance

    $2,193.0

     

    $2,192.0

     

    $2,119.0

     

    $2,246.0

     

    $2,217.0

     

    Debt Investment Portfolio Composition by Quarter

    (% of debt investment portfolio)

    Q3 2021

     

    Q2 2021

     

    Q1 2021

     

    Q4 2020

     

    Q3 2020

     

     

     

     

     

     

     

     

     

    First Lien Senior Secured

    80.8%

     

    82.1%

     

    82.7%

     

    84.2%

     

    85.5%

     

     

     

     

     

     

     

     

     

    Floating Rate w/Floors

    95.9%

     

    96.8%

     

    96.8%

     

    96.9%

     

    97.9%

     

    Effective Portfolio Yield and Core Portfolio Yield ("Core Yield")

    The effective yield on Hercules' debt investment portfolio was 12.7% during Q3 2021, as compared to 12.7% for Q2 2021. The Company realized $318.9 million of early loan repayments in Q3 2021 compared to $167.9 million in Q2 2021, or an increase of 89.9%. Effective yields generally include the effects of fees and income accelerations attributed to early loan repayments, and other one-time events. Effective yields are materially impacted by the elevated or reduced levels of early loan repayments and derived by dividing total investment income by the weighted average earning investment portfolio assets outstanding during the quarter, which excludes non-interest earning assets such as warrants and equity investments.

    Core yield, a non-GAAP measure, was 11.4% during Q3 2021, within the Company's expected range of 11.0% to 12.0%, and decreased slightly compared to 11.5% in Q2 2021. Hercules defines core yield as yields that generally exclude any benefit from income related to early repayments attributed to the acceleration of unamortized income and prepayment fees and includes income from expired commitments.

    Income Statement

    Total investment income decreased slightly to $70.2 million for Q3 2021, compared to $70.3 million in Q3 2020. The slight decrease is primarily attributable to an increase in total fee income offset by a decrease in interest income between periods.

    Non-interest and fee expenses were $18.7 million in Q3 2021 versus $15.0 million for Q3 2020. The increase was due to higher variable compensation, stock-based compensation and general and administrative expenses, due primarily to an increase in excise tax expenses.

    Interest expense and fees were $14.7 million in Q3 2021, compared to $16.6 million in Q3 2020. The decrease was due to a lower weighted-average borrowings between periods.

    The Company had a weighted average cost of borrowings comprised of interest and fees, of 4.9% in Q3 2021, as compared to 5.1% for Q3 2020. The decrease is primarily due to lower average higher-cost borrowings between periods.

    NII – Net Investment Income

    NII for Q3 2021 was $38.1 million, or $0.33 per share, based on 114.8 million basic weighted average shares outstanding, compared to $38.7 million, or $0.34 per share, based on 113.5 million basic weighted average shares outstanding in Q3 2020. The decrease is primarily attributable to a slight decrease in total investment income and a slight increase in the total net operating costs between periods.

    Continued Credit Discipline and Strong Credit Performance

    Hercules' net cumulative realized gain/(loss) position, since its first origination activities in October 2004 through September 30, 2021, (including net loan, warrant and equity activity) on investments, totaled ($65.1) million, on a GAAP basis, spanning 17 years of investment activities.

    When compared to total net new debt investment commitments during the same period of over $12.6 billion, the total realized gain/(loss) since inception of ($65.1) million represents approximately 52 basis points "bps," or 0.52%, of cumulative debt commitments, or an effective annualized loss rate of 3.0 bps, or 0.03%.

    Realized Gains/(Losses)

    During Q3 2021, Hercules had net realized gains of $21.1 million comprised of gross realized gains of $25.0 million due to the sale of equity and warrant investments, offset by ($3.9) million of gross realized losses primarily due to the loss on debt extinguishment and the write-off of one debt investment.

    Unrealized Appreciation/(Depreciation)

    During Q3 2021, Hercules recorded ($35.6) million of net unrealized depreciation on our debt, equity and warrant investments, primarily attributable to ($23.6) million of unrealized depreciation due to the reversal of unrealized appreciation upon acquisition or liquidation of our equity and warrant investments, and ($8.3) million of net unrealized depreciation attributable to valuation movements on the equity, warrant portfolio, and investment fund portfolio.

    Portfolio Asset Quality

    As of September 30, 2021, the weighted average grade of the debt investment portfolio, at cost, improved to 1.92, compared to 1.93 as of June 30, 2021, based on a scale of 1 to 5, with 1 being the highest quality. Hercules' policy is to generally adjust the credit grading down on its portfolio companies as they approach their expected need for additional growth equity capital to fund their respective operations for the next 9-14 months. Various companies in the Company's portfolio will require additional rounds of funding from time to time to maintain their operations.

    Additionally, Hercules may selectively downgrade portfolio companies, from time to time, if they are not meeting the Company's financing criteria, or underperforming relative to their respective business plans.

    As of September 30, 2021, grading of the debt investment portfolio at fair value, excluding warrants and equity investments, was as follows:

    Credit Grading (at Fair Value), Q3 2021 - Q3 2020 ($ in millions)

    Q3 2021

    Q2 2021

    Q1 2021

    Q4 2020

    Q3 2020

    Grade 1 - High

    $

    692.1

    30.6%

    $

    637.2

    28.4%

    $

    497.5

    22.8%

    $

    411.0

    19.6%

    $

    406.5

    17.9%

    Grade 2

    $

    1,103.8

    48.8%

    $

    1,192.7

    53.1%

    $

    1,240.7

    56.8%

    $

    1,027.9

    49.1%

    $

    1,053.1

    46.5%

    Grade 3

    $

    458.2

    20.2%

    $

    403.8

    18.0%

    $

    426.2

    19.5%

    $

    621.3

    29.7%

    $

    772.3

    34.1%

    Grade 4

    $

    8.3

    0.4%

    $

    8.4

    0.4%

    $

    20.4

    0.9%

    $

    25.3

    1.2%

    $

    26.7

    1.2%

    Grade 5 - Low

    $

    1.1

    0.0%

    $

    1.3

    0.1%

    $

    0.2

    0.0%

    $

    8.9

    0.4%

    $

    5.9

    0.3%

     
    Weighted Avg. (at Cost)

     

    1.92

     

    1.93

     

    2.01

     

    2.16

     

    2.22

    Non-Accruals

    Non-accruals remained the same as a percentage of the overall investment portfolio in the third quarter of 2021. As of September 30, 2021, the Company had three (3) debt investments on non-accrual with an investment cost and fair value of approximately $23.9 million and $8.7 million, respectively, or 1.0% and 0.3% as a percentage of the Company's total investment portfolio at cost and value, respectively.

    Compared to June 30, 2021, the Company had three (3) debt investments on non-accrual with an investment cost and fair value of approximately $23.0 million and $7.7 million, respectively, or 1.0% and 0.3% as a percentage of the total investment portfolio at cost and value, respectively.

    Q3 2021

     

    Q2 2021

     

    Q1 2021

     

    Q4 2020

     

    Q3 2020

     

     

     

     

     

     

     

     

     

    Total Investments at Cost

    $2,425.4

     

    $2,399.0

     

    $2,403.8

     

    $2,315.4

     

    $2,505.8

     

     

     

     

     

     

     

     

     

    Loans on non-accrual as a % of Total Investments at Value

    0.3%

     

    0.3%

     

    0.3%

     

    0.5%

     

    0.3%

     

     

     

     

     

     

     

     

     

    Loans on non-accrual as a % of Total Investments at Cost

    1.0%

     

    1.0%

     

    1.0%

     

    1.3%

     

    0.9%

     

    Liquidity and Capital Resources

    The Company ended Q3 2021 with $818.4 million in available liquidity, including $235.9 million in unrestricted cash and cash equivalents, and $582.5 million in available credit facilities and SBA debentures, subject to existing terms and advance rates and regulatory and covenant requirements.

    On July 1, 2021, the Company fully redeemed the aggregate outstanding $75.0 million of principal and $0.6 million of accrued interest pursuant to the redemption terms of the April 2025 Notes Indenture. The Company recognized a realized loss of $1.5 million due to the extinguishment of the debt.

    In September 2021, the Company closed an underwritten public offering of $325.0 million in aggregate principal amount of 2.625% notes due 2026 (the "Notes"). The Notes are unsecured and bear interest at a rate of 2.625% per year, payable semiannually and will mature on September 16, 2026, and may be redeemed in whole or in part at any time or from time to time at the Company's option at par, plus a "make-whole" premium, if applicable. The proceeds from the offering were used to redeem the aggregate outstanding principal and accrued interest of the 2027 and 2028 Asset-Backed Notes.

    Bank Facilities

    As of September 30, 2021, there were no outstanding borrowings under the Hercules' $400.0 million committed credit facility with Union Bank as Agent and no outstanding borrowings under the Hercules' $75.0 million committed credit facility with Wells Fargo Capital Finance.

    Leverage

    As of September 30, 2021, Hercules' GAAP leverage ratio, including its SBA debentures, was 106.4%. Hercules' regulatory leverage, or debt-to-equity ratio, excluding its SBA debentures, was 101.6% and net regulatory leverage, a non-GAAP measure (excluding cash of approximately $235.9 million), was 84.0%. Hercules' net leverage ratio, including its SBA debentures, was 88.8%. The leverage ratios in Q3 2021 do not reflect the impact of the redemption of the 2027 and 2028 Asset-Backed Notes which occurred subsequent to quarter end.

    Available Unfunded Commitments – Representing 11.1% of Total Assets

    The Company's unfunded commitments and contingencies consist primarily of unused commitments to extend credit in the form of loans to select portfolio companies. A portion of these unfunded contractual commitments are dependent upon the portfolio company reaching certain milestones in order to gain access to additional funding. Furthermore, the credit agreements the Company enters into with its portfolio companies contain customary lending provisions that allow us relief from funding obligations for previously made commitments. In addition, since a portion of these commitments may also expire without being drawn, unfunded contractual commitments do not necessarily represent future cash requirements.

    As of September 30, 2021, the Company had $309.9 million of available unfunded commitments at the request of the portfolio company and unencumbered by any milestones, including undrawn revolving facilities, representing 11.1% of Hercules' total assets. This decreased from the previous quarter of $327.3 million of available unfunded commitments or 12.7% of Hercules' total assets.

    Existing Pipeline and Signed Term Sheets

    After closing $719.6 million in new debt and equity commitments in Q3 2021, Hercules has pending commitments of $377.4 million in signed non-binding term sheets outstanding as of October 25, 2021. Since the close of Q3 2021 and as of October 25, 2021, Hercules has closed new gross debt and equity commitments of $125.0 million and funded $50.3 million.

    Signed non-binding term sheets are subject to satisfactory completion of Hercules' due diligence and final investment committee approval process as well as negotiations of definitive documentation with the prospective portfolio companies. These non-binding term sheets generally convert to contractual commitments in approximately 90 days from signing and some portion may be assigned or allocated to or directly originated by private funds managed by Hercules Adviser prior to or after closing. It is important to note that not all signed non-binding term sheets are expected to close and do not necessarily represent future cash requirements or investments.

    Net Asset Value

    As of September 30, 2021, the Company's net assets were $1.34 billion, compared to $1.36 billion at the end of Q2 2021. NAV per share decreased 1.5% to $11.54 on 115.9 million outstanding shares of common stock as of September 30, 2021, compared to $11.71 on 115.9 million outstanding shares of common stock as of June 30, 2021. The decrease in NAV per share was primarily attributed to the net change in unrealized depreciation between periods.

    Interest Rate Sensitivity

    Hercules has an asset sensitive debt investment portfolio with 95.9% of its debt investment portfolio being priced at floating interest rates as of September 30, 2021, with a Prime or LIBOR-based interest rate floor, combined with 100% of its outstanding debt borrowings bearing fixed interest rates, leading to higher net investment income sensitivity.

    Based on Hercules' Consolidated Statement of Assets and Liabilities as of September 30, 2021, the following table shows the approximate annualized increase/(decrease) in components of net income resulting from operations of hypothetical base rate changes in interest rates, such as Prime Rate, assuming no changes in Hercules' debt investments and borrowings. These estimates are subject to change due to the impact from active participation in the Company's equity ATM program and any future equity offerings.

    (in thousands) Interest Interest Net EPS(2)
    Basis Point Change Income(1) Expense Income

    (75)

    $

    (49

    )

    $

    (11

    )

    $

    (38

    )

    $

    -

    (50)

    $

    (49

    )

    $

    (11

    )

    $

    (38

    )

    $

    -

    (25)

    $

    (38

    )

    $

    (11

    )

    $

    (27

    )

    $

    -

    25

    $

    3,920

     

    $

    28

     

    $

    3,892

     

    $

    0.03

    50

    $

    7,840

     

    $

    56

     

    $

    7,784

     

    $

    0.07

    75

    $

    11,760

     

    $

    84

     

    $

    11,676

     

    $

    0.10

    100

    $

    15,730

     

    $

    111

     

    $

    15,619

     

    $

    0.14

    200

    $

    32,869

     

    $

    223

     

    $

    32,646

     

    $

    0.28

    (1)

    Source: Hercules Capital Form 10-Q for Q3 2021

    (2)

    EPS calculated on basic weighted shares outstanding of 114,805. Estimates are subject to change due to impact from active participation in the Company's equity ATM program and any future equity offerings.

    Existing Equity and Warrant Portfolio

    Equity Portfolio

    Hercules held equity positions in 71 portfolio companies with a fair value of $204.4 million and a cost basis of $135.6 million as of September 30, 2021. On a fair value basis, 52.9% or $108.6 million is related to existing public equity positions.

    Warrant Portfolio

    Hercules held warrant positions in 94 portfolio companies with a fair value of $42.9 million and a cost basis of $25.9 million as of September 30, 2021. On a fair value basis, 33.4% or $14.3 million is related to existing public warrant positions.

    Portfolio Company IPO and M&A Activity

    As of October 25, 2021 year-to-date, Hercules has had 33 portfolio companies complete or announce an IPO or M&A event, which is comprised of: 13 IPOs, 13 M&A events and seven (7) portfolio companies that have registered for the IPOs, or have entered into definitive agreements to go public via a merger or special purpose acquisition company, or "SPAC."

    IPO Activity in Q3 2021 and YTD Q4 2021

    As of October 25, 2021, Hercules held debt, warrant or equity positions in three (3) portfolio companies that have completed their IPOs and seven (7) companies that have registered for their IPOs or have entered into definitive agreements to go public via a merger or SPAC, including:

    Completed:

    • In August 2021, Hercules' portfolio company Rocket Lab (NASDAQ:RKLB), a developer of launch and space systems, completed its reverse merger initial public offering with Vector Acquisition Corp. (NASDAQ:VACQ), a SPAC. Hercules initially committed $100.0 million in venture debt financing beginning in June 2021.
    • In September 2021, Nerdy (NYSE:NRDY), the parent company of Hercules' portfolio company Varsity Tutors, a technology developer of an online tutoring platform, completed its reverse merger initial public offering with TPG Pace Tech Opportunities (NYSE:PACE), a SPAC. Hercules initially committed $50.0 million in venture debt financing beginning in August 2019 and currently holds 100,000 shares of common stock as of September 30, 2021.
    • In September 2021, Hercules' portfolio company VELO3D (NYSE:VLD), a developer of metal laser sintering printing machines intended to offer 3D printing, completed its reverse merger initial public offering with Jaws Spitfire Acquisition Corp. (NYSE:SPFR), a SPAC. Hercules initially committed $12.5 million in venture debt financing beginning in May 2021.

    In Registration or SPAC:

    • In October 2021, Hercules' portfolio company SeatGeek, a global technology ticketing marketplace and live entertainment technology platform, announced it has entered into a definitive agreement for a reverse merger initial public offering with RedBall Acquisition Corp. (NYSE:RBAC), a SPAC with a focus on sports, media and data analytics. Hercules initially committed $60.0 million in venture debt financing in June 2019 and currently holds warrants for 1,379,761 shares of common stock as of September 30, 2021.
    • In September 2021, Hercules' portfolio company Intuity Medical, a commercial-stage medical technology and digital health company focused on developing comprehensive solutions to improve the health and quality of life of people with diabetes, announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for an initial public offering. Intuity intends to list its common stock on the Nasdaq Global Select Market under the stock symbol "POGO." Hercules initially committed $30.0 million in venture debt financing beginning in December 2017 and currently hold warrants for 3,076,323 of Preferred Series B-1 stock as of September 30, 2021.
    • In July 2021, Hercules' portfolio company Gelesis Inc., a biotherapeutics company advancing superabsorbent hydrogels to treat excess weight and metabolic disorders, announced it has entered into a definitive agreement for a reverse merger initial public offering with Capstar Special Purpose Acquisition Corp. (NYSE:CPSR), a SPAC. Upon completion of the merger, the combined company will be listed on the New York Stock Exchange under the ticker symbol "GLS." Hercules initially committed $3.0 million in venture debt financing in August 2008 and currently holds 227,013 shares of common stock, 243,432 shares of Preferred Series A-1 stock and 191,626 shares of Preferred Series A-2 stock as of September 30, 2021.
    • In July 2021, Hercules' portfolio company Nextdoor, a provider of a social network that connects neighbors, announced it has entered into a definitive agreement for a reverse merger initial public offering with Khosla Ventures Acquisition Co. II (NASDAQ:KVSB), a SPAC. Upon completion of the merger, the combined company will be listed on the New York Stock Exchange under the ticker symbol "KIND." Hercules currently holds 328,190 shares of common stock as of September 30, 2021.
    • In July 2021, Hercules' portfolio company Planet Labs, an earth data and analytics company, announced it has entered into a definitive agreement for a reverse merger initial public offering with dMY Technology Group IV Inc. (NYSE:DMYQ), a SPAC. Upon completion of the merger, the combined company will be listed on the New York Stock Exchange under the ticker symbol "PL." Hercules initially committed $25.0 million in venture debt financing beginning in June 2019 and currently holds warrants for 357,752 shares of common stock as of September 30, 2021.
    • In May 2021, Hercules' portfolio company Valo Health LLC, a technology company using human-centric data and artificial intelligence powered computation to transform the drug discovery and development process, announced it has entered into a definitive agreement for a reverse merger initial public offering with Khosla Ventures Acquisition Co. (NASDAQ:KVAC), a SPAC. Upon completion of the merger, the combined company will be listed on the Nasdaq Global Select Market under the ticker symbol "VH." Hercules initially committed $20.0 million in venture debt financing beginning in June 2020 and currently holds 510,308 shares of Preferred Series B stock and warrants for 102,216 shares of common stock as of September 30, 2021.
    • In March 2021, Hercules' portfolio company Pineapple Energy, LLC, a U.S. operator and consolidator of residential solar, battery storage and grid services solutions, announced that it entered into a definitive merger agreement with Communications Systems, Inc. (NASDAQ:JCS), and IoT intelligent edge products and services company. Upon closing, CSI will commence doing business as Pineapple Energy, and expects shares of the combined company to continue to trade on the Nasdaq Global Select Market under the new ticker symbol "PEGY." Hercules initially committed $12.3 million in venture debt financing beginning in December 2010 and currently holds 17,647 shares of Class A Units as of September 30, 2021.

    There can be no assurances that companies that have yet to complete their IPOs will do so or that pending merger announcements will close.

    M&A Activity in Q3 2021 and YTD Q4 2021

    • In October 2021, Hercules' portfolio company Tapjoy, Inc., a mobile performance-based advertising platform that drives deep engagement and monetization opportunities for app developers, announced that they have entered into an agreement to be acquired by ironSource (NYSE:IS), a leading business platform for the App Economy, for approximately $400.0 million in cash. Hercules initially committed $20.0 million in venture debt financing beginning in July 2014 and currently holds warrants for 748,670 shares of Preferred Series D stock as of September 30, 2021.
    • In October 2021, Hercules' portfolio company OneLogin, Inc., a leader in Unified Access Management, announced that they have been acquired by One Identity, an industry leader in Privileged Access Management, Identity Governance Administration, and Active Directory Management and Security. Terms of the acquisition were not disclosed. Hercules initially committed $40.0 million in venture debt financing beginning in February 2016 and currently holds warrants for 381,620 shares of common stock as of September 30, 2021.
    • In October 2021, Hercules' portfolio company Clarabridge, a global leader in Customer Experience Management (CEM) for the world's top brands, was acquired by Qualtrics (NASDAQ:XM), the leader and creator of the Experience Management (XM) category, for $1.125 billion in stock. Hercules initially committed $40.0 million in venture debt financing beginning in March 2017.
    • In September 2021, Hercules' portfolio company Sapphire Digital, Inc., the healthcare industry's leading platform for provider selection, patient access, price transparency, and digital consumer navigation, announced that they entered into a definitive agreement to be acquired by Zelis, a leading payments company in healthcare. Terms of the acquisition were not disclosed. Hercules initially committed $15.0 million in venture debt financing beginning in May 2017 and currently holds warrants for 2,812,500 shares of common stock as of September 30, 2021.
    • In September 2021, Hercules' portfolio company Envisage Technologies, the leader in unified training, compliance, and performance software for public safety, was acquired Vector Solutions, the leading provider of industry-focused software solutions for training, workforce management and risk communications. Hercules initially committed $12.0 million in venture debt financing beginning in March 2020.

    Subsequent Events

    1. As of October 25, 2021, Hercules has:

    1. Funded $50.3 million to new and existing commitments since the close of the third quarter 2021.
    2. Pending commitments (signed non-binding term sheets) of $377.4 million.

    The table below summarizes the Company's year-to-date closed and pending commitments as follows:

    Closed Commitments and Pending Commitments (in millions)

    January 1 – September 30, 2021 Closed Commitments(a)(c)

    $1,691.4

    Q4 2021 Closed Commitments (as of October 25, 2021)(a)(c)

    $125.0

    Year-to-Date Closed Commitments

    $1,816.4

    Q4 2021 Pending Commitments (as of October 25, 2021)(b)

    $377.4

    Year-to-Date 2021 Closed and Pending Commitments(c)

    $2,193.8

    Notes:

    1. Closed Commitments may include renewals of existing credit facilities and equity commitments. Not all Closed Commitments result in future cash requirements. Commitments generally fund over the two succeeding quarters from close.
    2. Not all pending commitments (signed non-binding term sheets) are expected to close and do not necessarily represent any future cash requirements.
    3. Gross commitments before assignments to or direct originations by the Adviser Funds.

    2. On October 20, 2021, the Company fully redeemed the aggregate outstanding $289.2 million of principal and $1.1 million of accrued interest and fees pursuant to the redemption terms of the 2027 Asset-Backed and 2028 Asset-Backed Notes Indentures. The Company accelerated recognition of $2.7 million of debt issuance costs associated with the extinguishment of the debt in the fourth quarter, which would represent a $0.02 per share realized loss impact using the Company's weighted average shares for the most recent quarter.

    Conference Call

    Hercules has scheduled its third quarter 2021 financial results conference call for October 28, 2021 at 2:00 p.m. PT (5:00 p.m. ET). To listen to the call, please dial (877) 304-8957 (or (408) 427-3709 internationally) and reference Conference ID: 9145314 if asked, approximately 10 minutes prior to the start of the call. A taped replay will be made available approximately three hours after the conclusion of the call and will remain available for seven days. To access the replay, please dial (855) 859-2056 or (404) 537-3406 and enter the passcode 9145314.

    About Hercules Capital, Inc.

    Hercules Capital, Inc. (NYSE:HTGC) is the leading and largest specialty finance company focused on providing senior secured venture growth loans to high-growth, innovative venture capital-backed companies in a broad variety of technology, life sciences and sustainable and renewable technology industries. Since inception (December 2003), Hercules has committed more than $12.8 billion to over 540 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing. Companies interested in learning more about financing opportunities should contact [email protected], or call 650.289.3060.

    Hercules Capital, through its wholly owned subsidiary, Hercules Adviser LLC ("Hercules Adviser"), also maintains an asset management business through which it manages investments for external parties ("Adviser Funds"). Hercules Adviser is registered as an investment adviser under the Investment Advisers Act of 1940.

    Hercules' common stock trades on the New York Stock Exchange (NYSE) under the ticker symbol "HTGC." In addition, Hercules has one retail bond issuance of 6.25% Notes due 2033 (NYSE:HCXY).

    Category: Earnings

    Forward-Looking Statements

    This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. You should understand that under Section 27A(b)(2)(B) of the Securities Act of 1933, as amended, and Section 21E(b)(2)(B) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 do not apply to forward-looking statements made in periodic reports we file under the Exchange Act.

    The information disclosed in this press release is made as of the date hereof and reflects Hercules' most current assessment of its historical financial performance. Actual financial results filed with the SEC may differ from those contained herein due to timing delays between the date of this release and confirmation of final audit results. These forward-looking statements are not guarantees of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements including, without limitation, the risks, uncertainties, including the uncertainties surrounding the current market volatility, and other factors the Company identifies from time to time in its filings with the SEC. Although Hercules believes that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate and, as a result, the forward-looking statements based on those assumptions also could be incorrect. You should not place undue reliance on these forward-looking statements. The forward-looking statements contained in this release are made as of the date hereof, and Hercules assumes no obligation to update the forward-looking statements for subsequent events.

    HERCULES CAPITAL, INC.
    CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES
    (dollars in thousands, except per share data)
     
    September 30, 2021 December 31, 2020
    Assets
    Investments:
    Non-control/Non-affiliate investments (cost of $2,330,982 and $2,175,651, respectively)

    $

    2,436,307

    $

    2,288,338

    Control investments (cost of $81,020 and $65,257, respectively)

     

    65,835

     

    57,400

    Affiliate investments (cost of $13,387 and $74,450, respectively)

     

    9,712

     

    8,340

    Total investments in securities, at value (cost of $2,425,389 and $2,315,358, respectively)

     

    2,511,854

     

    2,354,078

    Cash and cash equivalents

     

    235,851

     

    198,282

    Restricted cash

     

    13,509

     

    39,340

    Interest receivable

     

    17,859

     

    19,077

    Right of use asset

     

    7,373

     

    9,278

    Other assets

     

    4,762

     

    3,942

    Total assets

    $

    2,791,208

    $

    2,632,997

     
    Liabilities
    Debt (net of debt issuance costs)(1)

    $

    1,408,701

    $

    1,286,638

    Accounts payable and accrued liabilities

     

    37,098

     

    36,343

    Operating lease liability

     

    7,877

     

    9,312

    Total liabilities

    $

    1,453,676

    $

    1,332,293

     
    Net assets consist of:
    Common stock, par value

     

    116

     

    115

    Capital in excess of par value

     

    1,166,725

     

    1,158,198

    Total distributable earnings

     

    170,691

     

    133,391

    Total net assets

    $

    1,337,532

    $

    1,291,704

    Total liabilities and net assets

    $

    2,791,208

    $

    2,623,997

     
    Shares of common stock outstanding ($0.001 par value, 200,000,000 authorized)

     

    115,925

     

    114,726

    Net asset value per share

    $

    11.54

    $

    11.26

     
    (1) The Company's SBA Debentures, February 2025 Notes, June 2025 Notes, 2033 Notes, 2022 Notes, 2027 Asset-Backed Notes, 2028 Asset-Backed Notes, 2022 Convertible Notes, July 2024 Notes, March 2026 A and B Notes, and September 2026 Notes as each term is defined herein, are presented net of the associated debt issuance costs for each instrument.
    HERCULES CAPITAL, INC.
    CONSOLIDATED STATEMENTS OF OPERATIONS
    (in thousands, except per share data)
     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

    2021

     

    2020

     

    2021

     

    2020

    Investment income:
    Interest income
    Non-control/Non-affiliate investments

    $

    62,239

     

    $

    64,403

     

    $

    185,497

     

    $

    192,408

     

    Control investments

     

    1,072

     

     

    740

     

     

    2,900

     

     

    2,117

     

    Affiliate investments

     

    1

     

     

    232

     

     

    3

     

     

    609

     

    Total interest income

     

    63,312

     

     

    65,375

     

     

    188,400

     

     

    195,134

     

    Fee income
    Commitment, facility and loan fee income
    Non-control/Non-affiliate investments

     

    5,179

     

     

    2,985

     

     

    13,845

     

     

    10,692

     

    Control investments

     

    20

     

     

    5

     

     

    43

     

     

    15

     

    Total commitment, facility and loan fee income

     

    5,199

     

     

    2,990

     

     

    13,888

     

     

    10,707

     

    One-time fee income
    Non-control/Non-affiliate investments

     

    1,682

     

     

    1,974

     

     

    6,223

     

     

    6,085

     

    Total one-time fee income

     

    1,682

     

     

    1,974

     

     

    6,223

     

     

    6,085

     

    Total fee income

     

    6,881

     

     

    4,964

     

     

    20,111

     

     

    16,792

     

    Total investment income

     

    70,193

     

     

    70,339

     

     

    208,511

     

     

    211,926

     

    Operating expenses:
    Interest

     

    13,069

     

     

    14,807

     

     

    42,309

     

     

    44,415

     

    Loan fees

     

    1,674

     

     

    1,824

     

     

    6,694

     

     

    5,268

     

    General and administrative
    Legal expenses

     

    314

     

     

    673

     

     

    1,268

     

     

    2,563

     

    Tax expenses

     

    2,395

     

     

    994

     

     

    5,579

     

     

    3,028

     

    Other expenses

     

    3,771

     

     

    3,624

     

     

    10,481

     

     

    11,622

     

    Total general and administrative

     

    6,480

     

     

    5,291

     

     

    17,328

     

     

    17,213

     

    Employee compensation
    Compensation and benefits

     

    8,898

     

     

    7,181

     

     

    27,051

     

     

    22,575

     

    Stock-based compensation

     

    3,320

     

     

    2,522

     

     

    8,990

     

     

    7,477

     

    Total employee compensation

     

    12,218

     

     

    9,703

     

     

    36,041

     

     

    30,052

     

    Total gross operating expenses

     

    33,441

     

     

    31,625

     

     

    102,372

     

     

    96,948

     

    Expenses allocated to the Adviser Subsidiary

     

    (1,337

    )

     

    —

     

     

    (3,474

    )

     

    —

     

    Total net operating expenses

     

    32,104

     

     

    31,625

     

     

    98,898

     

     

    96,948

     

    Net investment income

     

    38,089

     

     

    38,714

     

     

    109,613

     

     

    114,978

     

    Net realized gain (loss) and change in unrealized appreciation (depreciation):
    Net realized gain (loss)
    Non-control/Non-affiliate investments

     

    22,813

     

     

    (48,501

    )

     

    78,444

     

     

    (41,393

    )

    Affiliate investments

     

    —

     

     

    —

     

     

    (62,143

    )

     

    —

     

    Loss on debt extinguishment

     

    (1,702

    )

     

    —

     

     

    (1,702

    )

     

    —

     

    Total net realized gain (loss)

     

    21,111

     

     

    (48,501

    )

     

    14,599

     

     

    (41,393

    )

    Net change in unrealized appreciation (depreciation)
    Non-control/Non-affiliate investments

     

    (31,759

    )

     

    54,299

     

     

    (10,662

    )

     

    19,483

     

    Control investments

     

    (3,774

    )

     

    646

     

     

    (7,327

    )

     

    (4,563

    )

    Affiliate investments

     

    (118

    )

     

    (2,111

    )

     

    64,220

     

     

    (12,416

    )

    Total net unrealized appreciation (depreciation)

     

    (35,651

    )

     

    52,834

     

     

    46,231

     

     

    2,504

     

    Total net realized gain (loss) and change in unrealized appreciation (depreciation):

     

    (14,540

    )

     

    4,333

     

     

    60,830

     

     

    (38,889

    )

    Net increase (decrease) in net assets resulting from operations

    $

    23,549

     

    $

    43,047

     

    $

    170,443

     

    $

    76,089

     

     
    Net investment income before investment gains and losses per common share:
    Basic

    $

    0.33

     

    $

    0.34

     

    $

    0.95

     

    $

    1.03

     

    Change in net assets resulting from operations per common share:
    Basic

    $

    0.20

     

    $

    0.38

     

    $

    1.47

     

    $

    0.68

     

    Diluted

    $

    0.20

     

    $

    0.38

     

    $

    1.46

     

    $

    0.67

     

    Weighted average shares outstanding:
    Basic

     

    114,805

     

     

    113,489

     

     

    114,590

     

     

    111,342

     

    Diluted

     

    116,239

     

     

    113,744

     

     

    115,550

     

     

    111,590

     

    Distributions paid per common share:
    Basic

    $

    0.39

     

    $

    0.32

     

    $

    1.15

     

    $

    1.04

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20211028006057/en/

    Get the next $CPSR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CPSR
    $DMYQ
    $HCXY
    $HTGC

    CompanyDatePrice TargetRatingAnalyst
    Rocket Lab USA Inc.
    $RKLB
    4/25/2025$28.00Buy
    Needham
    Hercules Capital Inc.
    $HTGC
    12/12/2024$19.50 → $21.50Mkt Perform → Outperform
    Keefe Bruyette
    Nerdy Inc.
    $NRDY
    11/11/2024Neutral → Underweight
    JP Morgan
    Nerdy Inc.
    $NRDY
    11/8/2024Mkt Outperform → Mkt Perform
    JMP Securities
    Nerdy Inc.
    $NRDY
    11/8/2024$6.00 → $1.00Overweight → Neutral
    Cantor Fitzgerald
    Rocket Lab USA Inc.
    $RKLB
    9/12/2024Mkt Perform
    JMP Securities
    Nerdy Inc.
    $NRDY
    8/9/2024$5.00 → $3.00Buy → Hold
    Canaccord Genuity
    Nerdy Inc.
    $NRDY
    8/9/2024Overweight → Neutral
    JP Morgan
    More analyst ratings

    $CPSR
    $DMYQ
    $HCXY
    $HTGC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Rocket Lab to Launch NASA Astrophysics Science Mission on Electron to Study Galaxy Evolution

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or the "Company"), a global leader in launch services and space systems, today announced it has been selected by NASA to launch its Aspera mission, an astrophysics science mission designed to study the formation and evolution of galaxies and provide new insights into how the universe works. Rocket Lab will launch the Aspera spacecraft on Electron from Rocket Lab Launch Complex 1 no earlier than Q1 2026. Through the use of a telescope to study ultraviolet light, Aspera will examine hot gas in the space between galaxies, called the intergalactic medium, that is thought to contribute to the birth of stars and planets. Aspera will be the first N

      5/14/25 4:18:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Two Earth Return Missions in Two Months: Rocket Lab Demonstrates Rapid Re-entry Capability with Third Pioneer Spacecraft for Varda Space Industries

      Designed and built by Rocket Lab, the Pioneer spacecraft hosted Varda's capsule on orbit for 60 days Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a leading launch and space systems company, today announced its record turnaround of two Earth return missions in two months with its latest successful mission and Pioneer spacecraft for Varda Space Industries ("Varda"), a leading orbital pharmaceuticals and hypersonic re-entry logistics company. Rocket Lab successfully supported the return to Earth of Varda's W-3 capsule at 02:07 a.m. UTC on May 14, the third overall successful operation in the W-series of Varda missions. This press release features multimedia. View the fu

      5/14/25 5:13:00 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Altimmune Secures Up to $100 Million in Credit Facility from Hercules Capital

      GAITHERSBURG, Md., May 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that it has entered into an agreement with Hercules Capital, Inc. (NYSE:HTGC), a leader in debt financing for life science companies, for up to $100 million in a credit facility, with a $15 million tranche funded at closing. Additional tranches will become available upon achievement of certain clinical and financial milestones aligned with the Company's pemvidutide development plans and financing needs. Access to this additional capital strengthens Altimmune's ba

      5/13/25 7:00:00 AM ET
      $ALT
      $HTGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Investment Managers
      Finance

    $CPSR
    $DMYQ
    $HCXY
    $HTGC
    Leadership Updates

    Live Leadership Updates

    See more
    • Rocket Lab Awarded New HASTE Launch Contract for the DOD by Kratos

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced it has been selected by Kratos to launch a full-scale hypersonic test flight for the Department of Defense (DOD) under the Multi-Service Advanced Capability Hypersonic Test Bed (MACH-TB) 2.0 program. The mission will launch on Rocket Lab's HASTE rocket from Rocket Lab Launch Complex 2 on Wallops Island, Virginia no earlier than Q1, 2026. The launch agreement is the first full-scale flight test to be awarded by Kratos under the MACH-TB 2.0 contract, a $1.45 billion program designed to rapidly expand the number and frequency of opportunities to test hypers

      4/23/25 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • SolarEdge Appoints Shuki Nir as Chief Executive Officer

      SolarEdge Technologies, Inc. ("SolarEdge" or the "Company") (NASDAQ:SEDG), a global leader in smart energy technology, today announced the appointment of Mr. Shuki Nir as the Company's new Chief Executive Officer (CEO), effective immediately. Mr. Nir, who has served as SolarEdge's CMO since June 2024, will succeed Mr. Ronen Faier, who has served as the Company's Interim CEO since August 2024. Mr. Faier will stay on with the Company as an advisor during a transition period to ensure a seamless leadership transition. Mr. Nir is also replacing Mr. Zvi Lando as a member of the Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/n

      12/5/24 7:00:00 AM ET
      $KRNT
      $SEDG
      $IS
      Industrial Machinery/Components
      Industrials
      Semiconductors
      Technology
    • Comstock Welcomes Inova 360° Concierge Medicine to The Row at Reston Station

      New location to provide personalized healthcare option for the greater Reston community Comstock Holding Companies, Inc. (NASDAQ:CHCI) ("Comstock"), a leading asset manager, developer, and operator of mixed-use and transit-oriented properties in the Washington, D.C. region, announced today the signing of a 4,505 square foot lease with Inova 360° Concierge Medicine ("Inova") at 1880 Reston Row Plaza, located within The Row at Reston Station. Inova 360° Concierge Medicine is designed for individuals seeking a proactive and individualized approach to their primary care. Patients receive comprehensive one-on-one care from trained medical professionals with access to advanced technology and

      12/4/24 9:00:00 AM ET
      $CHCI
      $GOOGL
      $ICFI
      $SPOT
      Real Estate
      Finance
      Computer Software: Programming Data Processing
      Technology

    $CPSR
    $DMYQ
    $HCXY
    $HTGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

      SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      12/5/24 9:49:25 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Nerdy Inc.

      SC 13D/A - Nerdy Inc. (0001819404) (Subject)

      12/4/24 4:01:10 PM ET
      $NRDY
      Other Consumer Services
      Real Estate
    • Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

      SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      12/3/24 9:39:57 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $CPSR
    $DMYQ
    $HCXY
    $HTGC
    SEC Filings

    See more
    • SEC Form 10-Q filed by Rocket Lab USA Inc.

      10-Q - Rocket Lab USA, Inc. (0001819994) (Filer)

      5/8/25 4:30:52 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab USA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

      8-K - Rocket Lab USA, Inc. (0001819994) (Filer)

      5/8/25 4:17:18 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • SEC Form 10-Q filed by Nerdy Inc.

      10-Q - Nerdy Inc. (0001819404) (Filer)

      5/8/25 4:03:10 PM ET
      $NRDY
      Other Consumer Services
      Real Estate

    $CPSR
    $DMYQ
    $HCXY
    $HTGC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Theodosopoulos Nikos bought $104,923 worth of shares (5,999 units at $17.49), increasing direct ownership by 101% to 11,960 units (SEC Form 4)

      4 - Hercules Capital, Inc. (0001280784) (Issuer)

      5/9/25 4:22:23 PM ET
      $HTGC
      Investment Managers
      Finance
    • Director Loo Wade bought $104,923 worth of shares (5,999 units at $17.49), returned 5,645 shares to the company and was granted 5,645 shares, increasing direct ownership by 5% to 7,504 units (SEC Form 4)

      4 - Hercules Capital, Inc. (0001280784) (Issuer)

      5/9/25 4:22:04 PM ET
      $HTGC
      Investment Managers
      Finance
    • Director Crowell Gayle A bought $104,923 worth of shares (5,999 units at $17.49), increasing direct ownership by 9% to 69,344 units (SEC Form 4)

      4 - Hercules Capital, Inc. (0001280784) (Issuer)

      5/9/25 4:21:45 PM ET
      $HTGC
      Investment Managers
      Finance

    $CPSR
    $DMYQ
    $HCXY
    $HTGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $CPSR
    $DMYQ
    $HCXY
    $HTGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Director Theodosopoulos Nikos bought $104,923 worth of shares (5,999 units at $17.49), increasing direct ownership by 101% to 11,960 units (SEC Form 4)

      4 - Hercules Capital, Inc. (0001280784) (Issuer)

      5/9/25 4:22:23 PM ET
      $HTGC
      Investment Managers
      Finance
    • Director Loo Wade bought $104,923 worth of shares (5,999 units at $17.49), returned 5,645 shares to the company and was granted 5,645 shares, increasing direct ownership by 5% to 7,504 units (SEC Form 4)

      4 - Hercules Capital, Inc. (0001280784) (Issuer)

      5/9/25 4:22:04 PM ET
      $HTGC
      Investment Managers
      Finance
    • Director Crowell Gayle A bought $104,923 worth of shares (5,999 units at $17.49), increasing direct ownership by 9% to 69,344 units (SEC Form 4)

      4 - Hercules Capital, Inc. (0001280784) (Issuer)

      5/9/25 4:21:45 PM ET
      $HTGC
      Investment Managers
      Finance
    • Needham initiated coverage on Rocket Lab USA with a new price target

      Needham initiated coverage of Rocket Lab USA with a rating of Buy and set a new price target of $28.00

      4/25/25 8:32:44 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Hercules Capital upgraded by Keefe Bruyette with a new price target

      Keefe Bruyette upgraded Hercules Capital from Mkt Perform to Outperform and set a new price target of $21.50 from $19.50 previously

      12/12/24 8:09:58 AM ET
      $HTGC
      Investment Managers
      Finance
    • Nerdy downgraded by JP Morgan

      JP Morgan downgraded Nerdy from Neutral to Underweight

      11/11/24 7:42:47 AM ET
      $NRDY
      Other Consumer Services
      Real Estate

    $CPSR
    $DMYQ
    $HCXY
    $HTGC
    Financials

    Live finance-specific insights

    See more
    • MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update

      MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody® sonelokimab across portfolio of indications, including Phase 3 studies in hidradenitis suppurativa (HS), psoriatic Arthritis (PsA) and adolescent HS, as well as Phase 2 studies in palmoplantar pustulosis (PPP) and axial spondyloarthritis (axSpA)Announced completion of enrollment of patients in the Phase 3 program in HS (the VELA program) and disclosed baseline characteristics, replicating the Phase 2 MIRA trialPresented an interim readout of the Phase 2 LEDA study in PPP, highlighting the potential of sonelokimab

      5/12/25 4:00:00 PM ET
      $HTGC
      $MLTX
      Investment Managers
      Finance
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Rocket Lab Announces First Quarter 2025 Financial Results, Posting Quarterly Revenue of $123m Representing 32% Year-on-Year Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab," "the Company," "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter ended March 31, 2025. Rocket Lab founder and CEO Sir Peter Beck said: "Rocket Lab has delivered a strong first quarter performance, with wins across our launch and space systems divisions reflected in our near-record $123 million revenue – at the top end of our guidance and a 32% increase year-on-year compared to Q1 2024. We also remain confident in our ability to execute and deliver on what's set to be another strong quarter, with our Q2 2025 revenue guidance in the $130m-$140 million range

      5/8/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Nerdy Announces First Quarter 2025 Financial Results

      Nerdy announces the launch of Live + AI™ — a next-generation, AI-enhanced tutoring platform designed to accelerate learning. Nerdy beats the top end of revenue guidance in the first quarter; increases the low end of the revenue range for the full year; and reaffirms adjusted EBITDA guidance for the full year. Nerdy Inc. (NYSE:NRDY) today announced financial results for the first quarter ended March 31, 2025. "Our first-quarter results underscore the power of our Live + AI™ platform and our disciplined focus on high-quality, recurring revenue," said Chuck Cohn, Founder and CEO of Nerdy. "By pairing the empathy of expert educators with proprietary AI, we're driving stronger engagement and

      5/8/25 4:01:00 PM ET
      $NRDY
      Other Consumer Services
      Real Estate